Dieuwke Hooft Graafland

Dieuwke Hooft Graafland is a life sciences and healthcare regulatory expert with a solid track record in life sciences and healthcare M&A and litigation. She advises on high-profile transactions, precedent-setting cases, and complex regulatory challenges, helping clients navigate dynamic markets and shifting regulations. With expertise honed since 2011, she provides clients with regulatory clarity and actionable solutions.

Dieuwke acts for leading healthcare institutions, insurance companies, investors, and life sciences businesses active in medical devices, (bio)pharma, diagnostics, cosmetics, nutritionals, suppliers, biotech, medtech, and healthtech. She provides clear, practical advice on corporate structures, joint ventures, governance, market entry, financing, reimbursement, profit distribution, supervision, enforcement, advertising, licensing, and other compliance matters. Recognized by Legal 500 and Chambers, Dieuwke delivers pragmatic, clear, and solution-oriented advice tailored to the evolving life sciences and healthcare landscape. She frequently speaks and publishes on regulatory and market developments. Dieuwke worked in our Zurich (Switzerland) office in 2017.

Beyond her core practice, Dieuwke holds several notable ancillary positions. Since 2021, she serves as a board member of Bridges Network, a Dutch foundation dedicated to bridging the gap bicultural and first-generation law students and law firms in the Netherlands, fostering diversity and inclusion within the legal profession. In 2022, she was appointed by the Swiss government as ‘Vertrauensanwalt’ of the Swiss Embassy in the Netherlands.

For more information, please visit out website at https://www.loyensloeff.com/people/dieuwke-hooft-graafland/.